Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial
出版年份 2022 全文链接
标题
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial
作者
关键词
-
出版物
NATURE MEDICINE
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-05-20
DOI
10.1038/s41591-022-01789-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial
- (2021) Frances Humby et al. LANCET
- Fibroblast pathology in inflammatory joint disease
- (2021) Lucy‐Jayne Marsh et al. IMMUNOLOGICAL REVIEWS
- Emerging roles for IL-6 family cytokines as positive and negative regulators of ectopic lymphoid structures
- (2021) David G. Hill et al. CYTOKINE
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
- (2020) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- B cells and tertiary lymphoid structures promote immunotherapy response
- (2020) Beth A. Helmink et al. NATURE
- M3C: Monte Carlo reference-based consensus clustering
- (2020) Christopher R. John et al. Scientific Reports
- Notch signalling drives synovial fibroblast identity and arthritis pathology
- (2020) Kevin Wei et al. NATURE
- Translating IL-6 biology into effective treatments
- (2020) Ernest H. Choy et al. Nature Reviews Rheumatology
- PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets
- (2020) Ashley M. Curran et al. Nature Reviews Rheumatology
- A Pauci-Immune Synovial Pathotype Predicts Inadequate Response to TNFα-Blockade in Rheumatoid Arthritis Patients
- (2020) Alessandra Nerviani et al. Frontiers in Immunology
- An approach for normalization and quality control for NanoString RNA expression data
- (2020) Arjun Bhattacharya et al. BRIEFINGS IN BIOINFORMATICS
- Transforming clinical trials in rheumatology: towards patient-centric precision medicine
- (2020) Costantino Pitzalis et al. Nature Reviews Rheumatology
- Predicting treatment response to IL6R blockers in rheumatoid arthritis
- (2020) Bako Nouri et al. RHEUMATOLOGY
- The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus
- (2020) Roberto Giacomelli et al. AUTOIMMUNITY REVIEWS
- Dickkopf-3 links HSF1 and YAP/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts
- (2019) Nicola Ferrari et al. Nature Communications
- Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients
- (2019) Frances Humby et al. ANNALS OF THE RHEUMATIC DISEASES
- Distinct fibroblast subsets drive inflammation and damage in arthritis
- (2019) Adam P. Croft et al. NATURE
- Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry
- (2019) Fan Zhang et al. NATURE IMMUNOLOGY
- Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes
- (2019) Myles J. Lewis et al. Cell Reports
- Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: results from the pathobiology of early arthritis cohort (PEAC)
- (2019) Gloria Lliso-Ribera et al. ANNALS OF THE RHEUMATIC DISEASES
- B cell synovitis and clinical phenotypes in rheumatoid arthritis: relationship to disease stages and drug exposure
- (2019) F. Rivellese et al. Arthritis & Rheumatology
- Defining refractory rheumatoid arthritis
- (2018) Maya H Buch ANNALS OF THE RHEUMATIC DISEASES
- Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis
- (2018) Fumitaka Mizoguchi et al. Nature Communications
- Single-cell RNA-seq of rheumatoid arthritis synovial tissue using low-cost microfluidic instrumentation
- (2018) William Stephenson et al. Nature Communications
- Rheumatoid arthritis
- (2018) Josef S. Smolen et al. Nature Reviews Disease Primers
- Effect of rituximab treatment on T and B cell subsets in lymph node biopsies of patients with rheumatoid arthritis
- (2018) Tamara H Ramwadhdoebe et al. RHEUMATOLOGY
- Salmon provides fast and bias-aware quantification of transcript expression
- (2017) Rob Patro et al. NATURE METHODS
- Sample size requirements for learning to classify with high-dimensional biomarker panels
- (2017) Paul McKeigue STATISTICAL METHODS IN MEDICAL RESEARCH
- Effectiveness of Targeted Therapy in Patients With Previously Untreated Metastatic Breast Cancer: A Systematic Review and Meta-Analysis
- (2015) Paweł Kawalec et al. Clinical Breast Cancer
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- High expression levels of the B cell chemoattractant CXCL13 in rheumatoid synovium are a marker of severe disease
- (2014) Serena Bugatti et al. RHEUMATOLOGY
- voom: precision weights unlock linear model analysis tools for RNA-seq read counts
- (2014) Charity W Law et al. GENOME BIOLOGY
- Ultrasound-guided synovial biopsy: a safe, well-tolerated and reliable technique for obtaining high-quality synovial tissue from both large and small joints in early arthritis patients
- (2013) S Kelly et al. ANNALS OF THE RHEUMATIC DISEASES
- Molecular signatures of antibody responses derived from a systems biology study of five human vaccines
- (2013) Shuzhao Li et al. NATURE IMMUNOLOGY
- Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis
- (2012) John D Isaacs et al. ANNALS OF THE RHEUMATIC DISEASES
- Pretreatment synovial transcriptional profile is associated with early and late clinical response in rheumatoid arthritis patients treated with rituximab
- (2012) Vanessa E Hogan et al. ANNALS OF THE RHEUMATIC DISEASES
- Interferon type I signature may predict non response upon rituximab in rheumatoid arthritis patients
- (2012) Hennie G Raterman et al. ARTHRITIS RESEARCH & THERAPY
- Cutting Edge: Expression of XCR1 Defines Mouse Lymphoid-Tissue Resident and Migratory Dendritic Cells of the CD8 + Type
- (2011) K. Crozat et al. JOURNAL OF IMMUNOLOGY
- Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients
- (2010) Rogier M. Thurlings et al. ARTHRITIS AND RHEUMATISM
- Prolectin, a Glycan-binding Receptor on Dividing B Cells in Germinal Centers
- (2009) Sarah A. Graham et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Synovial Tissue Sublining CD68 Expression Is a Biomarker of Therapeutic Response in Rheumatoid Arthritis Clinical Trials: Consistency Across Centers
- (2009) B. BRESNIHAN et al. JOURNAL OF RHEUMATOLOGY
- The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation
- (2008) Bernard Vandooren et al. ARTHRITIS AND RHEUMATISM
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started